Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

ATS vs NOVT vs ROP vs MKSI

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ATS
ATS Corporation

Industrial - Machinery

IndustrialsNYSE • CA
Market Cap$3.36B
5Y Perf.+139.1%
NOVT
Novanta Inc.

Hardware, Equipment & Parts

TechnologyNASDAQ • US
Market Cap$4.86B
5Y Perf.+32.7%
ROP
Roper Technologies, Inc.

Industrial - Machinery

IndustrialsNASDAQ • US
Market Cap$36.28B
5Y Perf.-10.5%
MKSI
MKS Inc.

Hardware, Equipment & Parts

TechnologyNASDAQ • US
Market Cap$20.25B
5Y Perf.+184.8%

ATS vs NOVT vs ROP vs MKSI — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ATS logoATS
NOVT logoNOVT
ROP logoROP
MKSI logoMKSI
IndustryIndustrial - MachineryHardware, Equipment & PartsIndustrial - MachineryHardware, Equipment & Parts
Market Cap$3.36B$4.86B$36.28B$20.25B
Revenue (TTM)$2.80B$981M$8.12B$4.07B
Net Income (TTM)$19M$54M$1.71B$327M
Gross Margin25.9%44.4%69.4%45.2%
Operating Margin2.9%11.9%28.1%14.8%
Forward P/E27.2x38.2x16.1x30.4x
Total Debt$1.70B$342M$9.30B$4.69B
Cash & Equiv.$226M$381M$297M$675M

ATS vs NOVT vs ROP vs MKSILong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ATS
NOVT
ROP
MKSI
StockMay 20May 26Return
ATS Corporation (ATS)100239.1+139.1%
Novanta Inc. (NOVT)100132.7+32.7%
Roper Technologies,… (ROP)10089.5-10.5%
MKS Inc. (MKSI)100284.8+184.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: ATS vs NOVT vs ROP vs MKSI

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ROP leads in 6 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. MKS Inc. is the stronger pick specifically for recent price momentum and sentiment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
ATS
ATS Corporation
The Specific-Use Pick

ATS plays a supporting role in this comparison — it may shine differently against other peers.

Best for: industrials exposure
NOVT
Novanta Inc.
The Defensive Pick

NOVT is the clearest fit if your priority is sleep-well-at-night.

  • Lower volatility, beta 2.02, Low D/E 26.0%, current ratio 3.69x
Best for: sleep-well-at-night
ROP
Roper Technologies, Inc.
The Income Pick

ROP carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 12 yrs, beta 0.43, yield 0.9%
  • Rev growth 12.3%, EPS growth -1.0%, 3Y rev CAGR 13.7%
  • PEG 1.68 vs NOVT's 11.61
  • Beta 0.43, yield 0.9%, current ratio 0.52x
Best for: income & stability and growth exposure
MKSI
MKS Inc.
The Long-Run Compounder

MKSI is the #2 pick in this set and the best alternative if long-term compounding is your priority.

  • 7.5% 10Y total return vs NOVT's 8.5%
  • +306.1% vs ROP's -38.0%
Best for: long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthROP logoROP12.3% revenue growth vs ATS's -16.5%
ValueROP logoROPLower P/E (16.1x vs 30.4x)
Quality / MarginsROP logoROP21.1% margin vs ATS's 0.7%
Stability / SafetyROP logoROPBeta 0.43 vs MKSI's 2.64, lower leverage
DividendsROP logoROP0.9% yield, 12-year raise streak, vs MKSI's 0.3%, (2 stocks pay no dividend)
Momentum (1Y)MKSI logoMKSI+306.1% vs ROP's -38.0%
Efficiency (ROA)ROP logoROP5.0% ROA vs ATS's 0.4%, ROIC 6.1% vs 0.2%

ATS vs NOVT vs ROP vs MKSI — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ATSATS Corporation

Segment breakdown not available.

NOVTNovanta Inc.
FY 2025
Robotics and Automation
32.5%$319M
Advanced Surgery
24.7%$242M
Precision Medicine
24.2%$237M
Precision Manufacturing
18.6%$182M
ROPRoper Technologies, Inc.
FY 2025
Software And Related Services
100.0%$12.3B
MKSIMKS Inc.
FY 2025
Product
87.4%$3.4B
Service
12.6%$495M

ATS vs NOVT vs ROP vs MKSI — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLROPLAGGINGATS

Income & Cash Flow (Last 12 Months)

ROP leads this category, winning 4 of 6 comparable metrics.

ROP is the larger business by revenue, generating $8.1B annually — 8.3x NOVT's $981M. ROP is the more profitable business, keeping 21.1% of every revenue dollar as net income compared to ATS's 0.7%. On growth, ATS holds the edge at +16.6% YoY revenue growth, suggesting stronger near-term business momentum.

MetricATS logoATSATS CorporationNOVT logoNOVTNovanta Inc.ROP logoROPRoper Technologie…MKSI logoMKSIMKS Inc.
RevenueTrailing 12 months$2.8B$981M$8.1B$4.1B
EBITDAEarnings before interest/tax$228M$179M$3.2B$945M
Net IncomeAfter-tax profit$19M$54M$1.7B$327M
Free Cash FlowCash after capex$279M$48M$2.6B$401M
Gross MarginGross profit ÷ Revenue+25.9%+44.4%+69.4%+45.2%
Operating MarginEBIT ÷ Revenue+2.9%+11.9%+28.1%+14.8%
Net MarginNet income ÷ Revenue+0.7%+5.5%+21.1%+8.0%
FCF MarginFCF ÷ Revenue+10.0%+4.9%+31.4%+9.8%
Rev. Growth (YoY)Latest quarter vs prior year+16.6%+8.5%+11.3%+15.2%
EPS Growth (YoY)Latest quarter vs prior year+3.6%-2.2%+59.1%+53.2%
ROP leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

ROP leads this category, winning 5 of 7 comparable metrics.

At 24.8x trailing earnings, ROP trades at a 73% valuation discount to NOVT's 92.7x P/E. Adjusting for growth (PEG ratio), ROP offers better value at 2.59x vs NOVT's 28.13x — a lower PEG means you pay less per unit of expected earnings growth.

MetricATS logoATSATS CorporationNOVT logoNOVTNovanta Inc.ROP logoROPRoper Technologie…MKSI logoMKSIMKS Inc.
Market CapShares × price$3.4B$4.9B$36.3B$20.2B
Enterprise ValueMkt cap + debt − cash$4.4B$4.8B$45.3B$24.3B
Trailing P/EPrice ÷ TTM EPS-163.12x92.71x24.82x68.83x
Forward P/EPrice ÷ next-FY EPS est.27.21x38.25x16.08x30.36x
PEG RatioP/E ÷ EPS growth rate28.13x2.59x
EV / EBITDAEnterprise value multiple37.43x27.00x14.57x26.70x
Price / SalesMarket cap ÷ Revenue1.81x4.96x4.59x5.15x
Price / BookPrice ÷ Book value/share2.71x3.81x1.91x7.49x
Price / FCFMarket cap ÷ FCF100.38x14.55x40.74x
ROP leads this category, winning 5 of 7 comparable metrics.

Profitability & Efficiency

NOVT leads this category, winning 5 of 9 comparable metrics.

MKSI delivers a 12.2% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $1 for ATS. NOVT carries lower financial leverage with a 0.26x debt-to-equity ratio, signaling a more conservative balance sheet compared to MKSI's 1.73x. On the Piotroski fundamental quality scale (0–9), ROP scores 6/9 vs ATS's 3/9, reflecting solid financial health.

MetricATS logoATSATS CorporationNOVT logoNOVTNovanta Inc.ROP logoROPRoper Technologie…MKSI logoMKSIMKS Inc.
ROE (TTM)Return on equity+1.1%+4.1%+8.8%+12.2%
ROA (TTM)Return on assets+0.4%+3.0%+5.0%+3.7%
ROICReturn on invested capital+0.2%+7.4%+6.1%+6.5%
ROCEReturn on capital employed+0.3%+8.3%+7.7%+7.2%
Piotroski ScoreFundamental quality 0–93566
Debt / EquityFinancial leverage0.99x0.26x0.47x1.73x
Net DebtTotal debt minus cash$1.5B-$39M$9.0B$4.0B
Cash & Equiv.Liquid assets$226M$381M$297M$675M
Total DebtShort + long-term debt$1.7B$342M$9.3B$4.7B
Interest CoverageEBIT ÷ Interest expense0.81x4.89x6.50x2.84x
NOVT leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

MKSI leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in MKSI five years ago would be worth $16,648 today (with dividends reinvested), compared to $8,255 for ROP. Over the past 12 months, MKSI leads with a +306.1% total return vs ROP's -38.0%. The 3-year compound annual growth rate (CAGR) favors MKSI at 54.1% vs ROP's -7.6% — a key indicator of consistent wealth creation.

MetricATS logoATSATS CorporationNOVT logoNOVTNovanta Inc.ROP logoROPRoper Technologie…MKSI logoMKSIMKS Inc.
YTD ReturnYear-to-date+24.3%+22.6%-18.5%+78.8%
1-Year ReturnPast 12 months+36.5%+14.6%-38.0%+306.1%
3-Year ReturnCumulative with dividends-20.1%-15.2%-21.0%+266.0%
5-Year ReturnCumulative with dividends+46.3%+5.7%-17.5%+66.5%
10-Year ReturnCumulative with dividends+282.7%+853.7%+115.0%+750.6%
CAGR (3Y)Annualised 3-year return-7.2%-5.3%-7.6%+54.1%
MKSI leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — ATS and ROP each lead in 1 of 2 comparable metrics.

ROP is the less volatile stock with a 0.43 beta — it tends to amplify market swings less than MKSI's 2.64 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ATS currently trades 98.9% from its 52-week high vs ROP's 60.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricATS logoATSATS CorporationNOVT logoNOVTNovanta Inc.ROP logoROPRoper Technologie…MKSI logoMKSIMKS Inc.
Beta (5Y)Sensitivity to S&P 5001.87x2.02x0.43x2.64x
52-Week HighHighest price in past year$35.06$149.95$584.03$326.83
52-Week LowLowest price in past year$23.85$98.27$313.86$71.49
% of 52W HighCurrent price vs 52-week peak+98.9%+90.9%+60.3%+92.0%
RSI (14)Momentum oscillator 0–10061.662.643.665.3
Avg Volume (50D)Average daily shares traded145K375K1.2M1.2M
Evenly matched — ATS and ROP each lead in 1 of 2 comparable metrics.

Analyst Outlook

ROP leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: ATS as "Hold", NOVT as "Buy", ROP as "Buy", MKSI as "Buy". Consensus price targets imply 29.8% upside for ROP (target: $458) vs -9.3% for MKSI (target: $273). For income investors, ROP offers the higher dividend yield at 0.93% vs MKSI's 0.29%.

MetricATS logoATSATS CorporationNOVT logoNOVTNovanta Inc.ROP logoROPRoper Technologie…MKSI logoMKSIMKS Inc.
Analyst RatingConsensus buy/hold/sellHoldBuyBuyBuy
Price TargetConsensus 12-month target$34.00$150.00$457.64$272.86
# AnalystsCovering analysts232329
Dividend YieldAnnual dividend ÷ price+0.9%+0.3%
Dividend StreakConsecutive years of raises120
Dividend / ShareAnnual DPS$3.29$0.87
Buyback YieldShare repurchases ÷ mkt cap+1.3%+0.8%+1.4%+0.2%
ROP leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

ROP leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). NOVT leads in 1 (Profitability & Efficiency). 1 tied.

Best OverallRoper Technologies, Inc. (ROP)Leads 3 of 6 categories
Loading custom metrics...

ATS vs NOVT vs ROP vs MKSI: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is ATS or NOVT or ROP or MKSI a better buy right now?

For growth investors, Roper Technologies, Inc.

(ROP) is the stronger pick with 12. 3% revenue growth year-over-year, versus -16. 5% for ATS Corporation (ATS). Roper Technologies, Inc. (ROP) offers the better valuation at 24. 8x trailing P/E (16. 1x forward), making it the more compelling value choice. Analysts rate Novanta Inc. (NOVT) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — ATS or NOVT or ROP or MKSI?

On trailing P/E, Roper Technologies, Inc.

(ROP) is the cheapest at 24. 8x versus Novanta Inc. at 92. 7x. On forward P/E, Roper Technologies, Inc. is actually cheaper at 16. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Roper Technologies, Inc. wins at 1. 68x versus Novanta Inc. 's 11. 61x — a reasonable growth-adjusted valuation.

03

Which is the better long-term investment — ATS or NOVT or ROP or MKSI?

Over the past 5 years, MKS Inc.

(MKSI) delivered a total return of +66. 5%, compared to -17. 5% for Roper Technologies, Inc. (ROP). Over 10 years, the gap is even starker: NOVT returned +853. 7% versus ROP's +115. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — ATS or NOVT or ROP or MKSI?

By beta (market sensitivity over 5 years), Roper Technologies, Inc.

(ROP) is the lower-risk stock at 0. 43β versus MKS Inc. 's 2. 64β — meaning MKSI is approximately 516% more volatile than ROP relative to the S&P 500. On balance sheet safety, Novanta Inc. (NOVT) carries a lower debt/equity ratio of 26% versus 173% for MKS Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — ATS or NOVT or ROP or MKSI?

By revenue growth (latest reported year), Roper Technologies, Inc.

(ROP) is pulling ahead at 12. 3% versus -16. 5% for ATS Corporation (ATS). On earnings-per-share growth, the picture is similar: MKS Inc. grew EPS 55. 5% year-over-year, compared to -114. 7% for ATS Corporation. Over a 3-year CAGR, ROP leads at 13. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — ATS or NOVT or ROP or MKSI?

Roper Technologies, Inc.

(ROP) is the more profitable company, earning 19. 4% net margin versus -1. 1% for ATS Corporation — meaning it keeps 19. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ROP leads at 28. 3% versus 0. 4% for ATS. At the gross margin level — before operating expenses — ROP leads at 69. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is ATS or NOVT or ROP or MKSI more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Roper Technologies, Inc. (ROP) is the more undervalued stock at a PEG of 1. 68x versus Novanta Inc. 's 11. 61x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Roper Technologies, Inc. (ROP) trades at 16. 1x forward P/E versus 38. 2x for Novanta Inc. — 22. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ROP: 29. 8% to $457. 64.

08

Which pays a better dividend — ATS or NOVT or ROP or MKSI?

In this comparison, ROP (0.

9% yield), MKSI (0. 3% yield) pay a dividend. ATS, NOVT do not pay a meaningful dividend and should not be held primarily for income.

09

Is ATS or NOVT or ROP or MKSI better for a retirement portfolio?

For long-horizon retirement investors, Roper Technologies, Inc.

(ROP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 43), 0. 9% yield, +115. 0% 10Y return). ATS Corporation (ATS) carries a higher beta of 1. 87 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ROP: +115. 0%, ATS: +282. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between ATS and NOVT and ROP and MKSI?

These companies operate in different sectors (ATS (Industrials) and NOVT (Technology) and ROP (Industrials) and MKSI (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

ROP pays a dividend while ATS, NOVT, MKSI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

ATS

High-Growth Disruptor

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 8%
  • Gross Margin > 15%
Run This Screen
Stocks Like

NOVT

Quality Business

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

ROP

Quality Mega-Cap Compounder

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 12%
Run This Screen
Stocks Like

MKSI

High-Growth Disruptor

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform ATS and NOVT and ROP and MKSI on the metrics below

Revenue Growth>
%
(ATS: 16.6% · NOVT: 8.5%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.